HIF1A and neoplasm: Conversely, HIF-1α inhibition can enhance T cell anti-tumor activity and inhibit glycolysis, and reducing HIF-1α levels in the TME can increase memory T cell production and improve anti-tumor function (Sukumar et al., 2013).